Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz. - Wikidata - awgldk - TriplyDB

Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.

Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.

http://www.wikidata.org/entity/Q44731169

about

Individualization of antiretroviral therapy--pharmacogenomic aspect Efavirenz and the CNS: what we already know and questions that need to be answered Quality of Sleep in an HIV Population on Antiretroviral Therapy at an Urban Tertiary Centre in Lagos, Nigeria.Burden of sleep disturbances and associated risk factors: A cross-sectional survey among HIV-infected persons on antiretroviral therapy across China.Neurological and psychiatric adverse effects of antiretroviral drugs.Efavirenz modulation of sleep spindles and sleep spectral profile.Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring.Pharmacogenomics of antimicrobial agents.Population pharmacokinetic/pharmacogenetic model for optimization of efavirenz therapy in Caucasian HIV-infected patients.Association of Markers of Inflammation with Sleep and Physical Activity Among People Living with HIV or AIDS Insomnia symptoms and HIV infection among participants in the Women's Interagency HIV Study.Prevalence and factors associated with sleep disturbances among early-treated HIV-infected persons Efavirenz for HIV-1 infection in adults: an overview.The nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in the treatment of HIV.Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose.Neuropsychiatric side effects of efavirenz therapy.Efavirenz: a review.Cost-effectiveness of CYP2B6 genotyping to optimize efavirenz dosing in HIV clinical practice.Qualitative study of the quality of sleep in marginalized individuals living with HIV.The pharmacologic management of insomnia in patients with HIV.Effect of rifampicin-based antitubercular therapy and the cytochrome P450 2B6 516G>T polymorphism on efavirenz concentrations in adults in South Africa.The impact of pharmacogenetics on HIV therapy.Multiphenotype association study of patients randomized to initiate antiretroviral regimens in AIDS Clinical Trials Group protocol A5202.A systematic review of the psychiatric side-effects of efavirenz.Antiretroviral drug-related toxicities - clinical spectrum, prevention, and management.Impact of CYP polymorphisms, ethnicity and sex differences in metabolism on dosing strategies: the case of efavirenz.Pharmacogenetics of antiretroviral therapy.Dual antiviral therapy for HIV and hepatitis C - drug interactions and side effects.Cytochrome 2B6 polymorphism and efavirenz-induced central nervous system symptoms : a substudy of the ANRS ALIZE trial.Engagement in Care, Psychological Distress, and Resilience are Associated with Sleep Quality among HIV-Positive Gay, Bisexual, and Other Men Who Have Sex with Men.Impact of pharmacogenetics on CNS side effects related to efavirenz.Pharmacogenetics of efavirenz discontinuation for reported central nervous system symptoms appears to differ by race.Caffeine and Insomnia in People Living With HIV From the Miami Adult Studies on HIV (MASH) Cohort.Drug interactions in HIV-infected patients treated for hepatitis C.Effect of Valerian in Preventing Neuropsychiatric Adverse Effects of Efavirenz in HIV-Positive Patients: A Pilot Randomized, Placebo-Controlled Clinical Trial.Sleep Disturbance Among HIV-Infected and Uninfected Veterans.Impact of efavirenz pharmacokinetics and pharmacogenomics on neuropsychological performance in older HIV-infected patients.Changes in sleep quality and brain wave patterns following initiation of an efavirenz-containing triple antiretroviral regimen.Long-term efficacy and safety of efavirenz dose reduction to 200 mg once daily in a Caucasian patient with HIV.Influence of 516G>T polymorphisms at the gene encoding the CYP450-2B6 isoenzyme on efavirenz plasma concentrations in HIV-infected subjects.

P2860

Q28070574-B6FBEA74-521E-4B01-85F8-7C42CB44DE42 Q28085028-4CE02952-BD9F-486A-8A00-50C28D7A0ED1 Q33607553-99525030-9262-41D4-AF5F-E5BD73D8A15D Q33807989-B189C32F-CE77-495A-AD53-AAFB0ECAF4B9 Q34039419-145DF2B4-410A-4302-B118-4ADEE4B56A16 Q34433247-7B42D703-3FEF-4A5B-A7F7-A179A128C721 Q34464997-953E17A0-FEE5-4040-86A7-C0E5F0D3190C Q34977413-F0D89374-911D-45C8-A8A1-85DA32A13DE1 Q35364120-F4B9937E-10E2-4EA3-B0DD-7CFAE4950CC0 Q35612351-8A8D2C70-2C1F-49D3-8E58-BDBC88525199 Q35623512-CA18E438-F68E-4CCD-9B33-CDC7128AD313 Q35906888-89880684-1153-4CC3-BBDF-601D1CD99A2F Q35917519-732E5E6A-51B9-4290-AEFF-B9BD1EE8D74B Q36271415-FAFF548B-4C51-4DC4-860A-E9A9DA094F45 Q36729929-FD2118D3-FF98-4F93-AB37-D9102539F6F7 Q36762436-B03F6419-F85B-4501-8FA3-DBF3E128DD1C Q36787311-3B75B555-A5DF-41C8-B2E2-E36A7BC86729 Q36801543-5021D861-91CD-4A85-BCB9-592544305B77 Q36943576-97EDEEC8-2BD5-4614-AD86-023BA065BFA0 Q37234441-E84A8887-AA18-43CF-8A99-2F92C1DF0F2C Q37334180-F7B8A838-3DE8-4C81-939C-B54F72F68F25 Q37405140-CD995ECF-0FDA-46CD-BFEF-960DEC120219 Q37617319-1FAD9FB7-D916-4249-AD4D-A52CF0D2F8F2 Q37864141-BB0B04C7-C5C7-4250-A375-62F743D2A131 Q38111430-EFD266C7-52F9-404A-B803-CA7F14420CAE Q38175870-17052F8C-B783-441C-A713-1CD492BF9CA8 Q38221179-4150AE06-6FC7-4843-829C-AA6DD4A9168D Q38554604-9E060D7D-F2C5-4B70-B79E-FBC4FF0CCD4E Q38987587-51A79883-2CB4-45EA-A737-F91AA291436E Q39303354-0B773CE4-FEB2-4768-A122-D465234597E8 Q39383647-1C1D4020-39B2-4EEC-ADB6-BF506359C5EB Q39503882-35E9CC5A-AD9A-4006-9433-84956F7B907A Q40074833-76380326-F360-46BC-8D3B-30F09071D897 Q40143109-E2B4E911-E702-4E47-8F3F-BFC14EECF4A9 Q40223622-4D5C86AA-455F-4EA0-BBC3-78C2CDC2556C Q40427690-F9121BB8-7B3C-4E65-9266-ED01A550147F Q40531475-9C5D2968-1A7B-46CD-9F47-6FF1C6A55622 Q42683724-29A998A2-2027-4D8F-8484-9F9817FC6DDB Q43074797-A2B081A2-58E0-421E-985E-028CA1F9C8ED Q46433672-46366F0A-2531-4F56-9DDE-461D0127BCE9

P2860

Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.

http://www.wikidata.org/entity/Q44731169

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.

@en

Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.

@nl

type

label

Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.

@en

Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.

@nl

prefLabel

Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.

@en

Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.

@nl

P1433

Q44731169-E7E1B3BF-E6DA-465C-B556-6F9FF748C525

P1476

Q44731169-92C893C4-41E2-4644-8CE8-D3DAA1A17697

P2093

Q44731169-4655E3A7-8DB8-4A2D-BFF3-4D82056F1902

Q44731169-512E8288-BB8E-444E-8D86-87F66CE5BDCE

Q44731169-80754FCC-CD0D-4E41-8F93-9126D15938E2

Q44731169-8539BB1A-D2A7-4C80-BF75-A6692AA0DF55

Q44731169-BBAE9110-4566-4A02-9BCA-61D415D6AB9C

Q44731169-EB704500-4746-48B1-B05D-735174C8F934

P2860

Q44731169-371BCE9A-149E-476A-A5CE-4768762679C6

Q44731169-3DD9E405-DFDD-4ABF-BA11-5DD803F0C4FF

Q44731169-5675D85D-3A55-400F-9FE3-638594786568

Q44731169-A73A7FA2-D848-47BC-934D-AB02123CE6F5

Q44731169-B602845D-2770-455D-8E09-025658FBA9AD

Q44731169-BA345622-EA22-4ABD-BF2F-6A367AD7E258

Q44731169-BEEB0910-8C07-4AA8-B91D-72D904F2F267

Q44731169-C20A1B59-41F1-464E-BEEA-1B2A31E3BE57

Q44731169-C56B9202-55F9-422D-BA0F-A6DBF481F1E7

P304

Q44731169-617FA7E8-4D69-4D95-8F60-2BE270035867

P31

Q44731169-4855EB9B-5100-4AE4-8AD8-88EB1E006663

P356

Q44731169-6890CDD6-956B-40B0-93BF-C1ED502999A3

P407

Q44731169-D0050C72-6279-4434-ACA3-3A3E70BE5632

P433

Q44731169-6A833FA7-F84C-425A-98AC-1B2FA4CC3F7C

P478

Q44731169-B764C15A-0B7E-49B2-8FDB-2094B40F3F81

P50

Q44731169-0DC60B57-D1F9-40B6-B247-E724FC6EDF86

P577

Q44731169-DBFEEC84-D35F-4375-9029-21441E2B3473

P5875

Q44731169-7A4EE701-DB86-4895-9EDD-C2596206C1D5

P698

Q44731169-EC53582F-1A8E-4559-88F8-74D02C07F847

P921

Q44731169-19C985D9-AAB3-4CD2-BD84-ADF44A656C6A

P356

P1433

Clinical Infectious Diseases

P1476

Analyzing sleep abnormalities in HIV-infected patients treated with Efavirenz.

@en

P2093

Apolinar Rodríguez-Albariño

http://www.w3.org/2001/XMLSchema#string

Daniel González de Requena

http://www.w3.org/2001/XMLSchema#string

Juan González-Lahoz

http://www.w3.org/2001/XMLSchema#string

Lucía Gallego

http://www.w3.org/2001/XMLSchema#string

Pablo Barreiro

http://www.w3.org/2001/XMLSchema#string

Rafael del Río

http://www.w3.org/2001/XMLSchema#string

P2860

The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research

Ambulatory EEG monitoring.

Human slow wave sleep: a review and appraisal of recent findings, with implications for sleep functions, and psychiatric illness.

High prevalence of insomnia in an outpatient population with HIV infection.

Effects of drugs on sleep.

Higher efavirenz plasma levels correlate with development of insomnia.

Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study.

Drug-induced nightmares.

Preliminary Data of a Prospective Study on Neuropsychiatric Side Effects After Initiation of Efavirenz

P304

430-432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/380791

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

Vicente Soriano

P577

2004-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8916801

http://www.w3.org/2001/XMLSchema#string

P698

14727217

http://www.w3.org/2001/XMLSchema#string

P921